AbCellera Closes $105 Million Series B Financing to Further Advance World-Leading Antibody Drug Discovery Platform
Amount Raised
$105 Million
Round Type
Series B
Investors
Description
AbCellera announced today that it has closed a US$105 million Series B financing. The financing was led by OrbiMed and current investor DCVC Bio, with an investor syndicate that includes Viking Global Investors, Peter Thiel, Founders Fund, Eli Lilly and Company, University of Minnesota, and Presight Capital. With the proceeds of the financing, AbCellera will expand its capacity and invest in technologies that complement and extend its proprietary antibody discovery engine.
Quick answer
AbCellera raised $105 Million in a Series B round, dated May 27, 2020. Investors: Thiel Capital.
- How much did AbCellera raise?
- AbCellera raised $105 Million in a Series B round on May 27, 2020.
- Who invested in AbCellera?
- Thiel Capital is named as investors in this round.
- What does AbCellera do?
- AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology.
- Where is AbCellera based and how big is it?
- Fundz records about 610 employees.
- Who are the decision-makers at AbCellera?
- Fundz holds 2 contacts at AbCellera, including the Infectious Disease. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Pharmaceutical and Biotechnology around the same time
Companies in the same sectors as AbCellera that raised within 45 days of this round, from Fundz verified event records.
- Amylyx Pharmaceuticals raised $30M on July 1, 2020.
- Helus Pharma raised $1.5M on June 29, 2020.
- Anebulo Pharmaceuticals raised $3M (Seed) on June 25, 2020.
- Azora Therapeutics, Inc. (DE) raised $5.2M on June 17, 2020.
- Mereo Biopharma Group plc raised $70M on June 12, 2020.
- LeonaBio, Inc. raised $89M on June 12, 2020.
Who to call at AbCellera, and when
A new round usually means AbCellera is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day AbCellera raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AbCellera, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AbCellera. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AbCellera raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAbCellera raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.